Curtis JR, Yamaoka K, Chen YH, Bhatt DL, et al. Malignancy risk with tofacitinib versus TNF inhibitors in rheumatoid arthritis: results from the open-label, randomised controlled ORAL Surveillance trial. Ann Rheum Dis 2022 Dec 5:annrheumdis-2022-222543. doi: 10.1136/ard-2022-222543.
PMID: 36600185